<DOC>
	<DOCNO>NCT00364884</DOCNO>
	<brief_summary>Keto-/amino acid supplement low protein diet reduce uremic symptom , improve nutritional status , delay dialysis therapy enhance health-related quality life patient stage V CKD comparison non-supplemented low protein diet .</brief_summary>
	<brief_title>Keto-/Amino Acid Supplemented Low Protein Diet Patients With Chronic Kidney Disease</brief_title>
	<detailed_description>Fifty patient include study . The study comprise 9 visit . The treatment period cover 6 month , precede 2-week screening period 1 month run-in period . Patients required visit investigator two time start active treatment . All patient qualify study randomise receive medication/introduction dietary management use standard simple randomization method.Group I patient receive keto-/amino acid ( Ketosteril ) supplement low protein diet active treatment period Group II patient receive non-supplemented low protein diet period . The daily dose keto-/amino acid Group I patient one tablet every 5 kg body weight . The total daily dose divide three time day .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<criteria>1 . Serum creatinine ≧6 mg/dl Visit 12 . Creatinine clearance &lt; 15 ml/min Visit 13 . Urine output ≧ 1,000 ml/day4 . Primary renal disease : chronic glomerulonephritis nondiabetic stage Ⅴ chronic kidney disease ( confirm biopsy clinical presentations/symptoms ) 5 . Bilaterally reduce renal size show sonography6 . Male female patient age 20 – 657 . Ability patient understand basic implication study follow instructions8 . Willingness participate indicated sign write informed consent 1 . Severe arterial hypertension responsive medical therapy , maximum blood pressure value allow : 180/100 mm Hg 2 . Inadequate caloric intake due extremely severe uremia ( vomit , anorexia , etc ) 3 . Malnutrition status serum albumin level le 3.5 g/dl recent one month 4 . Lack adherence dietary prescription 5 . Water sodium retention responsive diuretic 6 . Clinical relevant severe cardiac disease , hepatic disorder ( total bilirubin &gt; 1.5 time upper limit normal ) , malabsorption disorder , disease require steroid nonsteroid antiinflammatory drug 7 . Severe sodium waste syndrome may affect renal function markedly independently dietary therapy 8 . Concurrent use nephrotoxic drug 9 . Severe infection catabolic situation 10 . Signs uremic pericarditis 11 . Symptoms uremic polyneuropathy 12 . Disorder amino acid metabolism 13 . Pregnant nursing woman 14 . Participation clinical trial within last 2 month 15 . Former participation present study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>chronic kidney disease</keyword>
</DOC>